1. Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer. (16th October 2013) Authors: Liew, Mun Sem; Sia, Joseph; Starmans, Maud H. W.; Tafreshi, Ali; Harris, Sam; Feigen, Malcolm; White, Shane; Zimet, Allan; Lambin, Philippe; Boutros, Paul C.; Mitchell, Paul; John, Thomas Journal: Cancer medicine Issue: Volume 2:Number 6(2013:Dec.) Page Start: 916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial. Issue 5 (May 2020) Authors: King, Madeleine T; Link, Emma K; Whelan, Tim J; Olivotto, Ivo A; Kunkler, Ian; Westenberg, Antonia Helen; Gruber, Guenther; Schofield, Penny; Chua, Boon H; Chua, Boon H; Phillips, Claire; Bryant, Guy; Westenberg, Helen; Purohit, Om Pra-Kesh; Ahern, Verity; Graham, Peter; Akra, Mohamed; McArdle, O... Journal: Lancet oncology Issue: Volume 21:Issue 5(2020) Page Start: 685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Should Cancer Survivors Fear Radiation-Induced Sarcomas?. (1997) Authors: Feigen, Malcolm Journal: Sarcoma Issue: Volume 1:Number 2(1997) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗